Daryl Freeman

2.0k total citations
39 papers, 1.4k citations indexed

About

Daryl Freeman is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Sociology and Political Science. According to data from OpenAlex, Daryl Freeman has authored 39 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pulmonary and Respiratory Medicine, 20 papers in Physiology and 6 papers in Sociology and Political Science. Recurrent topics in Daryl Freeman's work include Chronic Obstructive Pulmonary Disease (COPD) Research (22 papers), Asthma and respiratory diseases (19 papers) and Respiratory and Cough-Related Research (10 papers). Daryl Freeman is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (22 papers), Asthma and respiratory diseases (19 papers) and Respiratory and Cough-Related Research (10 papers). Daryl Freeman collaborates with scholars based in United Kingdom, United States and Canada. Daryl Freeman's co-authors include David Price, Alison Chisholm, Elizabeth F. Juniper, Ronald J. Halbert, Sharon Isonaka, Dmitry Nonikov, Robert J. Nordyke, Erika Sims, Dermot Ryan and Rupert Jones and has published in prestigious journals such as New England Journal of Medicine, Journal of Allergy and Clinical Immunology and European Respiratory Journal.

In The Last Decade

Daryl Freeman

37 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daryl Freeman United Kingdom 17 1.2k 786 97 95 81 39 1.4k
Hana Muellerova United Kingdom 18 1.2k 1.0× 571 0.7× 65 0.7× 73 0.8× 153 1.9× 30 1.3k
Md Mostafizur Rahman Bangladesh 4 1.3k 1.1× 544 0.7× 92 0.9× 56 0.6× 163 2.0× 13 1.5k
José Antonio Quintano Spain 14 1.2k 1.0× 664 0.8× 49 0.5× 80 0.8× 105 1.3× 18 1.3k
DS Postma United States 4 1.3k 1.1× 641 0.8× 72 0.7× 51 0.5× 97 1.2× 4 1.4k
Ann-Christin Jonsson Sweden 9 1.0k 0.9× 635 0.8× 85 0.9× 45 0.5× 89 1.1× 9 1.2k
Josefin Sundh Sweden 19 872 0.7× 412 0.5× 72 0.7× 80 0.8× 106 1.3× 88 1.1k
Alison Chisholm United Kingdom 25 1.4k 1.2× 1.2k 1.6× 77 0.8× 34 0.4× 108 1.3× 57 1.8k
Miguel Román-Rodríguez Spain 23 1.4k 1.2× 1.1k 1.3× 56 0.6× 34 0.4× 131 1.6× 65 1.6k
Carlos Cabrera Spain 10 1.1k 0.9× 391 0.5× 86 0.9× 67 0.7× 238 2.9× 22 1.3k
Jorge Zagaceta Spain 10 1.1k 1.0× 384 0.5× 83 0.9× 64 0.7× 235 2.9× 13 1.3k

Countries citing papers authored by Daryl Freeman

Since Specialization
Citations

This map shows the geographic impact of Daryl Freeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daryl Freeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daryl Freeman more than expected).

Fields of papers citing papers by Daryl Freeman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daryl Freeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daryl Freeman. The network helps show where Daryl Freeman may publish in the future.

Co-authorship network of co-authors of Daryl Freeman

This figure shows the co-authorship network connecting the top 25 collaborators of Daryl Freeman. A scholar is included among the top collaborators of Daryl Freeman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daryl Freeman. Daryl Freeman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marco, Fabiano Di, Arschang Valipour, Claudio Jommi, et al.. (2025). Single-Inhaler Triple Therapy in Primary Care Across Europe: Expert Panel Consensus on the Consequences of Payer-Driven Access Rules and Call to Action. International Journal of COPD. Volume 20. 1595–1612.
2.
Levy, Mark L, Richard Beasley, Toby Capstick, et al.. (2024). A simple and effective evidence-based approach to asthma management: ICS-formoterol reliever therapy. British Journal of General Practice. 74(739). 86–89. 1 indexed citations
3.
Price, David, Rikke Buhl, Adrian Chan, et al.. (2018). The Role of FeNO in Cough Management : A Randomised Controlled Trial. Aberdeen University Research Archive (Aberdeen University). 1 indexed citations
4.
5.
King, Christine, David Price, Alan Kaplan, et al.. (2015). Long-acting muscarinic antagonist use in adults with asthma: real-life prescribing and outcomes of add-on therapy with tiotropium bromide. Journal of Asthma and Allergy. 8. 1–1. 40 indexed citations
6.
Price, David, Guy Brusselle, Nicolás Roche, Daryl Freeman, & Alison Chisholm. (2015). Real-world research and its importance in respiratory medicine. Breathe. 11(1). 26–38. 56 indexed citations
7.
Hardinge, Maxine, Simon Bourne, Brendan Cooper, et al.. (2015). British Thoracic Society guidelines for home oxygen use in adults: accredited by NICE. Thorax. 70(Suppl 1). i1–i43. 203 indexed citations
8.
Price, David, Anna Rigazio, Dirkje S. Postma, et al.. (2014). Blood eosinophilia and the number of exacerbations in COPD patients. European Respiratory Journal. 44(Suppl 58). 4416–4416. 14 indexed citations
9.
Jones, Rupert, David Price, Dermot Ryan, et al.. (2014). Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort. The Lancet Respiratory Medicine. 2(4). 267–276. 136 indexed citations
10.
11.
Price, David A., David Halpin, Robert J. Winter, et al.. (2011). Missed opportunities to diagnose COPD. European Respiratory Journal. 38(Suppl 55). 182–182. 1 indexed citations
12.
Price, David, Stanley D. Musgrave, Lee Shepstone, et al.. (2011). Leukotriene Antagonists as First-Line or Add-on Asthma-Controller Therapy. New England Journal of Medicine. 364(18). 1695–1707. 169 indexed citations
13.
Wilson, Ed, Erika Sims, Stanley D. Musgrave, et al.. (2010). Cost Effectiveness of Leukotriene Receptor Antagonists versus Inhaled Corticosteroids for Initial Asthma Controller Therapy. PharmacoEconomics. 28(7). 585–595. 9 indexed citations
14.
Wilson, Ed, David Price, Stanley D. Musgrave, et al.. (2010). Cost Effectiveness of Leukotriene Receptor Antagonists versus Long-Acting Beta-2 Agonists as Add-On Therapy to Inhaled Corticosteroids for Asthma. PharmacoEconomics. 28(7). 597–608. 14 indexed citations
15.
Freeman, Daryl & David J. Price. (2006). Primary care and palliative care. BMJ. 333(7560). 188–190. 16 indexed citations
16.
Freeman, Daryl, Robert J. Nordyke, Sharon Isonaka, et al.. (2005). Questions for COPD diagnostic screening in a primary care setting. Respiratory Medicine. 99(10). 1311–1318. 56 indexed citations
17.
Price, David, Daryl Freeman, Alan Kaplan, et al.. (2005). Progressive breathlessness in COPD — The role of hyperinflation and its pharmacological management. Primary Care Respiratory Journal. 14(6). 285–293. 4 indexed citations
18.
Price, David, David G. Tinkelman, Ronald J. Halbert, et al.. (2005). Symptom-Based Questionnaire for Identifying COPD in Smokers. Respiration. 73(3). 285–295. 176 indexed citations
19.
Price, David & Daryl Freeman. (2002). The BREATH (Breathlessness Research, Expectations and Treatment Hopes) study: a study in four countries. Primary Care Respiratory Journal. 11. 1 indexed citations
20.
Chapman, Kenneth R., Harvey Kreisman, Robert N. Rivington, et al.. (1990). A comparison of enprofylline and theophylline in the maintenance therapy of chronic reversible obstructive airway disease. Journal of Allergy and Clinical Immunology. 85(2). 514–521. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hana Muellerova Breakdown of academic impact, for papers by Md Mostafizur Rahman Breakdown of academic impact, for papers by José Antonio Quintano Breakdown of academic impact, for papers by DS Postma Breakdown of academic impact, for papers by Ann-Christin Jonsson Breakdown of academic impact, for papers by Josefin Sundh Breakdown of academic impact, for papers by Alison Chisholm Breakdown of academic impact, for papers by Miguel Román-Rodríguez Breakdown of academic impact, for papers by Carlos Cabrera Breakdown of academic impact, for papers by Jorge Zagaceta
Rankless by CCL
2026